← Leaderboards
James L. Gulley
Basic Sciences
$1,096,273
Attributed
$2,615,872
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $642.1K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,615,872 · 2
By mechanism
U01$2,615,872 · 2
Top collaborators
- Philip W Kantoff3 shared
- Jian Cao2 shared
- Christian Hinrichs2 shared
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsMalignant NeoplasmsImmunotherapyLaboratoriesT-LymphocyteResponseVaccinesTumorMalignant Neoplasm Of ProstateSafetyImmuneImmune ResponseBaseClinical ResearchAntibodiesResearch PersonnelCancer VaccinesRandomizedRecombinantsCancer PatientCancer TherapyImmunologicsRecombinant VaccinesCells
Grant awards (75)
Office of Sponsor and Regulatory Oversight$18,493,892
ZID · FY2025 · CA · contact PI
Cancer Immunotherapy$4,841,882
ZIA · FY2025 · CA · contact PI
Clinical Research Support for the CCR$2,522,792
ZID · FY2025 · CA · contact PI
Basic Research Support for the CCR$2,282,526
ZIC · FY2025 · CA · contact PI
Office of Translational Resources$1,201,329
ZIC · FY2025 · CA · contact PI
E7 TCR-T cell therapy for HPV-associated cancers$627,893
U01 · FY2025 · CA
Developing Tumor Infiltrating Lymphocyte Therapy for Patients with HIV and Cancer$143,907
ZIA · FY2025 · CA · contact PI
Bench to Beside and Back translational immuno-onocology-Cures$50
ZIA · FY2025 · CA · contact PI
Clinical Research Support for the CCR$7,074,637
ZID · FY2024 · CA · contact PI
Basic Research Support for the CCR$6,592,276
ZIC · FY2024 · CA · contact PI
Cancer Immunotherapy$4,195,237
ZIA · FY2024 · CA · contact PI
Office of Translational Resources$2,251,020
ZIC · FY2024 · CA · contact PI
E7 TCR-T cell therapy for HPV-associated cancers$642,086
U01 · FY2024 · CA
Bench to Beside and Back translational immuno-onocology-Cures$270,790
ZIA · FY2024 · CA · contact PI
CCR Office of Training and Education$160,787
ZIJ · FY2024 · CA · contact PI
Cancer Immunotherapy$4,037,445
ZIA · FY2023 · CA · contact PI
NCI-Alliance immune-related Adverse Events (irAE) Biorepository-Cures$191,131
ZIA · FY2023 · CA · contact PI
Bench to Beside and Back translational immuno-onocology-Cures$124,779
ZIA · FY2023 · CA · contact PI
T-Cell Receptor Gene Therapy for Human Cancers-Cures$33,240
ZIA · FY2023 · CA · contact PI
T-Cell Receptor Gene Therapy for Human Cancers-Cures$973,782
ZIA · FY2022 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$715,531
ZIA · FY2022 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$429,318
ZIA · FY2022 · CA · contact PI
Cellular Therapy$286,212
ZIA · FY2022 · CA · contact PI
Bench to Beside and Back translational immuno-onocology-Cures$70,148
ZIA · FY2022 · CA · contact PI
T-Cell Receptor Gene Therapy for Human Cancers-Cures$4,051,073
ZIA · FY2021 · CA · contact PI
Medical Oncology Service Clinical Core$2,257,611
ZID · FY2021 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$494,990
ZIA · FY2021 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$494,990
ZIA · FY2021 · CA · contact PI
Medical Oncology HIV-AIDS Clinical Research$398,401
ZID · FY2021 · CA · contact PI
Medical Oncology Service Clinical Core$2,862,970
ZID · FY2020 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$688,838
ZIA · FY2020 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$688,838
ZIA · FY2020 · CA · contact PI
Medical Oncology HIV-AIDS Clinical Research$505,230
ZID · FY2020 · CA · contact PI
Medical Oncology Service Clinical Core$1,288,963
ZID · FY2019 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$846,484
ZIA · FY2019 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$846,484
ZIA · FY2019 · CA · contact PI
Medical Oncology HIV-AIDS Clinical Research$227,464
ZID · FY2019 · CA · contact PI
Medical Oncology Service Clinical Core$1,811,346
ZID · FY2018 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$835,822
ZIA · FY2018 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$835,822
ZIA · FY2018 · CA · contact PI
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer$416,435
U01 · FY2018 · CA
Medical Oncology HIV-AIDS Clinical Research$319,650
ZID · FY2018 · CA · contact PI
Medical Oncology Service Clinical Core$1,582,071
ZID · FY2017 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$633,201
ZIA · FY2017 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$633,201
ZIA · FY2017 · CA · contact PI
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer$458,934
U01 · FY2017 · CA
Medical Oncology HIV-AIDS Clinical Research$279,189
ZID · FY2017 · CA · contact PI
Medical Oncology Service Clinical Core$1,433,173
ZID · FY2016 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$787,127
ZIA · FY2016 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$787,127
ZIA · FY2016 · CA · contact PI
Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer$470,524
U01 · FY2016 · CA
Medical Oncology HIV-AIDS Clinical Research$252,913
ZID · FY2016 · CA · contact PI
Medical Oncology Fellowship Program$6,114,523
ZIE · FY2015 · CA · contact PI
Medical Oncology Service Clinical Core$2,148,345
ZID · FY2015 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$324,191
ZIA · FY2015 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$324,191
ZIA · FY2015 · CA · contact PI
Medical Oncology Fellowship Program$6,360,176
ZIE · FY2014 · CA · contact PI
Medical Oncology Service Clinical Core$2,725,789
ZID · FY2014 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$292,739
ZIA · FY2014 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$292,739
ZIA · FY2014 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$767,212
ZIA · FY2013 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$767,212
ZIA · FY2013 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$853,223
ZIA · FY2012 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$853,223
ZIA · FY2012 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$657,066
ZIA · FY2011 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$657,066
ZIA · FY2011 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$843,113
ZIA · FY2010 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$843,113
ZIA · FY2010 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$863,733
ZIA · FY2009 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$863,733
ZIA · FY2009 · CA · contact PI
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines$517,380
Z01 · FY2008 · CA · contact PI
Clinical trials employing cancer vaccine combination therapies$517,380
Z01 · FY2008 · CA · contact PI
Vaccine Clinical Trials$1,173,524
Z01 · FY2007 · CA · contact PI
Vaccine Clinical Trials$0
Z01 · FY2006 · BC · contact PI
Vaccine Clinical Trials$0
Z01 · FY2005 · BC